Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [798]

Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes...

Dr Jonathan Anker - Mount Sinai Hospital, New York, USA

Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-invasive bladder cancer ( Dr Jonathan Anker - Mount Sinai Hospital, New York, USA )

AMVAC plus nivolumab in muscle-invasive bladder cancer preserves bladder and...

Dr Pooja Ghatalia - Fox Chase Cancer Center, Pennsylvania, USA

AMVAC plus nivolumab in muscle-invasive bladder cancer preserves bladder and predicts metastatic control with ctDNA ( Dr Pooja Ghatalia - Fox Chase Cancer Center, Pennsylvania, USA )

225Ac-PSMA-trillium shows high PSA response and favourable safety in metastatic...

Prof Fred Saad - University of Montreal, Montreal, Canada

225Ac-PSMA-trillium shows high PSA response and favourable safety in metastatic castration-resistant prostate cancer ( Prof Fred Saad - University of Montreal, Montreal, Canada )

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )

DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing...

Dr Lizzel van der Snee, Dr Max Lahaye and Dr Niels Kok

DW-MRI reduces futile surgery in colorectal peritoneal metastases undergoing cytoreductive surgery ( Dr Lizzel van der Snee, Dr Max Lahaye and Dr Niels Kok )

From lived experience to informed choice in breast cancer reconstruction

Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC

From lived experience to informed choice in breast cancer reconstruction ( Louise McKenna-Mayes - Co-Founder, TONIBOBANDLOU CIC )

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative...

Prof Marjolein Smidt - Maastricht University Medical Center, Maastricht...

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative breast cancer after 5 years ( Prof Marjolein Smidt - Maastricht University Medical Center, Maastricht, Netherlands )

IPSO guidelines on minimally invasive surgery in paediatric solid tumours

Dr Israel Fernandez-Pineda - Children’s Health Ireland at Crumlin, Dublin...

IPSO guidelines on minimally invasive surgery in paediatric solid tumours ( Dr Israel Fernandez-Pineda - Children’s Health Ireland at Crumlin, Dublin, Ireland )

ESMO 2025: Precision medicine in bladder cancer

Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix...

ESMO 2025: Precision medicine in bladder cancer ( Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos )

ESMO 2025: Bladder cancer highlights

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ESMO 2025: Bladder cancer highlights ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer

Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer ( Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany )

Molecular assay may help identify NSCLC patients who could benefit from...

Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer